J. Wolfe

发表

Can COMT Val158Met Gene Polymorphism Predict Treatment Outcomes for Methylphenidates in ADHD Patients?

Rhea Maheshwari, J. Wolfe, 2021, Journal of Student Research.

Facilitated intramolecular conjugate addition of N-(p-methoxyphenyl)-3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-dienyl)-3,3-diemthylpropionamide. I: Product characterization

R. Borchardt, D. Velde, J. Wolfe, 1992 .

Facilitated Intramolecular Conjugate Addition of N‐(p‐Methoxyphenyl)‐3‐ (3′,6′‐dioxo‐2′,4′‐dimethylcyclohexa‐1′,4′‐dienyl)‐3,3‐ dimethylpropionamide. Part 1. Product Characterization.

R. Borchardt, D. Velde, J. Wolfe, 1993 .

Improved Folding Yields of a Model Protein Using Protein Disulfide Isomerase

Chengan Du, J. Wolfe, J. M. Ye, 1998, Pharmaceutical Research.

Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.

J. Laurence, W. Zhou, Nicholas J. Boylan, 2013, Bioconjugate chemistry.

Antibody–Drug Conjugates: An Overview of the CMC and Characterization Process

P. Ross, J. L. Wolfe, J. Wolfe, 2016 .

Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.

P. Ross, J. L. Wolfe, J. Wolfe, 2016, Journal of pharmaceutical sciences.

Photoinduced aggregation of a model antibody-drug conjugate.

M. Wolfe, C. Schöneich, J. L. Wolfe, 2015, Molecular pharmaceutics.

Degradation of antiflammin 2 under acidic conditions.

G. Potti, J. Wolfe, J. M. Ye, 1996, Journal of pharmaceutical sciences.

Oxidative Degradation of Antiflammin 2

J. Wolfe, J. M. Ye, 1996, Pharmaceutical Research.

Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.

J. Laurence, W. Zhou, Nicholas J. Boylan, 2013, Bioconjugate chemistry.